Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AVANOS MEDICAL, INC.HYH · Entity 28189 | SVP, Chief Operating Officer | November 07, 2017 | November 09, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AVANOS MEDICAL, INC.
Report date November 07, 2017 · Filed November 09, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,191 |
Reported balance
After 2017-11-07 transaction · row 1
1 source rowRow 1 · 2017-11-07 · Tax withholding · Disposed 6,422 · Balance 15,191 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ACCENDRA HEALTH INC/VA/
Report date March 31, 2022 · Filed April 04, 2022
Section 16 reporting ended · disclosed 2022-04-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 232,120 |
Reported balance
After 2022-03-31 transaction · row 1
1 source rowRow 1 · 2022-03-31 · Tax withholding · Disposed 46,240 · Balance 232,120 F1: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2022 Filed Apr 4, 2022 12:42 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 46,240 | $44.71 | $2,067,390.40 |
DisclosureSEC source: 0001062993-22-009255 · form4.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · Former Pres, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,120 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 23:55 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 61,166 | $42.77 | $2,616,069.82 |
DisclosureSEC source: 0001062993-22-007019 · form4.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,360 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 23:44 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 96,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-003847 · form4.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,526 F1 · security: Restricted stock which vests on March 15, 2023. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 12:42 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 19,428 | $48.36 | $939,460.37 |
DisclosureSEC source: 0000075252-21-000121 · edgar.xml · nonDerivative · entry 6 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,974 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. F7 · price: Weighted average of the sale price range of $47.96 through $48.95. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 12:42 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 17,832 | $47.24 | $842,455.01 |
DisclosureSEC source: 0000075252-21-000121 · edgar.xml · nonDerivative · entry 5 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,402 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. F6 · price: Weighted average of the sale price range of $46.90 through $47.82. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 12:42 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 6,440 | $46.62 | $300,252.12 |
DisclosureSEC source: 0000075252-21-000121 · edgar.xml · nonDerivative · entry 4 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,234 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. F5 · price: Weighted average of the sale price range of $45.90 through $46.86. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 12:42 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 2,300 | $45.15 | $103,849.60 |
DisclosureSEC source: 0000075252-21-000121 · edgar.xml · nonDerivative · entry 3 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,674 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. F4 · price: Weighted average of the sale price range of $44.60 through $45.56. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 12:42 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 4,100 | $43.82 | $179,645.60 |
DisclosureSEC source: 0000075252-21-000121 · edgar.xml · nonDerivative · entry 2 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,974 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. F3 · price: Weighted average of the sale price range of $43.38 through $44.36. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 12:42 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 1,900 | $43.06 | $81,812.10 |
DisclosureSEC source: 0000075252-21-000121 · edgar.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,074 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. F2 · price: Weighted average of the sale price range of $42.34 through $43.34. Read SEC document |
| May 11, 2021 Filed May 13, 2021 12:57 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 7,403 | $33.41 | $247,334.23 |
DisclosureSEC source: 0000075252-21-000099 · edgar.xml · nonDerivative · entry 3 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,974 F4 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with conversion of performance share units to common stock. Read SEC document |
| May 11, 2021 Filed May 13, 2021 12:57 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 3,478 | $33.46 | $116,356.49 |
DisclosureSEC source: 0000075252-21-000099 · edgar.xml · nonDerivative · entry 2 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,377 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. F3 · price: Weighted average of the sale price range of $33.26 through $33.76. Read SEC document |
| May 11, 2021 Filed May 13, 2021 12:57 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 5,532 | $32.95 | $182,273.87 |
DisclosureSEC source: 0000075252-21-000099 · edgar.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,855 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. F2 · price: Weighted average of the sale price range of $32.26 through $33.25. Read SEC document |
| May 03, 2021 Filed May 5, 2021 12:04 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Exercise / conversionPerformance Share Unit · Derivative | 61,882 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000075252-21-000093 · edgar.xml · derivative · entry 5 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 61,882 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.expiration_date: The performance share units vest and convert to shares of OMI common stock on the exercise date. Read SEC document |
| May 03, 2021 Filed May 5, 2021 12:04 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 27,909 | $36.09 | $1,007,235.81 |
DisclosureSEC source: 0000075252-21-000093 · edgar.xml · nonDerivative · entry 4 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,387 F4 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with conversion of performance share units to common stock. Read SEC document |
| May 03, 2021 Filed May 5, 2021 12:04 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 1,600 | $37.04 | $59,257.60 |
DisclosureSEC source: 0000075252-21-000093 · edgar.xml · nonDerivative · entry 3 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,296 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. F3 · price: Weighted average of the purchase price range of $37.02 through $37.07. Read SEC document |
| May 03, 2021 Filed May 5, 2021 12:04 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 32,373 | $36.63 | $1,185,952.48 |
DisclosureSEC source: 0000075252-21-000093 · edgar.xml · nonDerivative · entry 2 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,896 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. F2 · price: Weighted average of the purchase price range of $36.02 through $37.01. Read SEC document |
| May 03, 2021 Filed May 5, 2021 12:04 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Exercise / conversionCommon Stock | 61,882 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-21-000093 · edgar.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 22:22 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 3,140 | $38.54 | $121,018.74 |
DisclosureSEC source: 0000075252-21-000070 · edgar.xml · nonDerivative · entry 4 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,387 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. F5 · price: Weighted average of the purchase price range of $38.32 through $38.72. Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 22:22 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 9,674 | $37.73 | $364,961.32 |
DisclosureSEC source: 0000075252-21-000070 · edgar.xml · nonDerivative · entry 3 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,527 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. F4 · price: Weighted average of the purchase price range of $37.29 through $38.26. Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 22:22 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 3,458 | $38.55 | $133,295.53 |
DisclosureSEC source: 0000075252-21-000070 · edgar.xml · nonDerivative · entry 2 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,201 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. F3 · price: Weighted average of the purchase price range of $38.34 through $38.72. Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 22:22 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 11,806 | $37.73 | $445,487.60 |
DisclosureSEC source: 0000075252-21-000070 · edgar.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,659 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. F2 · price: Weighted average of the purchase price range of $37.29 through $38.26. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 14:16 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 7,484 | $31.89 | $238,664.76 |
DisclosureSEC source: 0000075252-21-000060 · edgar.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,465 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:01 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 27,827 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-21-000054 · edgar.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,949 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 21:20 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 123,024 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-21-000025 · edgar.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,122 F1 · security: Restricted stock which vests on March 4, 2022. Read SEC document |
| February 10, 2021 Filed May 5, 2021 01:59 UTC Amendment | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantPerformance Share Unit · Derivative | 61,882 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000075252-21-000090 · edgar.xml · derivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,882 Underlying: Common Stock · 61,882 shares Expires not disclosed F1 · security: Amendment to Form 4 to report award of earned performance share units. F2 · derivative.expiration_date: The performance share units vest and convert to shares of OMI common stock on the exercise date. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:24 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 6,749 | $29.29 | $197,678.21 |
DisclosureSEC source: 0000075252-21-000017 · edgar.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,098 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:06 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 48,276 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-20-000064 · edgar.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,847 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| May 01, 2020 Filed May 5, 2020 23:17 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 43,255 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-20-000049 · edgar.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,571 Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 22:15 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 6,296 | $6.74 | $42,435.04 |
DisclosureSEC source: 0000075252-20-000027 · edgar.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,316 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| January 06, 2020 Filed Jan 7, 2020 21:19 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 9,243 | $5.17 | $47,786.31 |
DisclosureSEC source: 0000075252-20-000005 · edgar.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,612 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:39 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 61,512 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-19-000045 · edgar.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,855 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 19:35 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 8,890 | $6.51 | $57,873.90 |
DisclosureSEC source: 0000075252-19-000001 · edgar.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,343 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| February 08, 2018 Filed Feb 12, 2018 21:22 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 22,013 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-18-000029 · edgar.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,233 F1 · security: Restricted stock with three year vesting date. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 14:57 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 26,110 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-18-000010 · edgar.xml · nonDerivative · entry 2 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,220 F2 · security: Restricted stock with a two year vesting date. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 14:57 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 26,110 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-18-000010 · edgar.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · President, Global Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,110 F1 · security: Restricted stock with one year vesting date. Read SEC document |
| November 07, 2017 Filed Nov 9, 2017 16:27 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | Tax withholdingCommon Stock | 6,422 | $45.67 | $293,292.74 |
DisclosureSEC source: 0001606498-17-000067 · wf-form4_151024482947011.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · SVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,191 Read SEC document |
| May 03, 2017 Filed May 5, 2017 20:35 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | GrantEmployee Stock Option (right to buy) · Derivative | 46,016 | $0.00 Strike: $36.74 | $0.00 |
DisclosureSEC source: 0001606498-17-000032 · wf-form4_149401649422670.xml · derivative · entry 1 Lowery Christopher M · CIK 0001623959 · SVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,016 Underlying: Common Stock · 46,016 shares Expires 2027-05-03 F1 · derivative.exercise_date: The awards vest 30% on May 3, 2018, 30% on May 3, 2019, and 40% on May 3, 2020, subject to earlier vesting in the event of death, disability or certain other events. Read SEC document |
| April 30, 2017 Filed May 3, 2017 22:51 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | Tax withholdingCommon Stock | 1,950 | $39.50 | $77,025.00 |
DisclosureSEC source: 0001606498-17-000024 · wf-form4_149385189051302.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · SVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,613 Read SEC document |
| May 01, 2016 Filed Jan 19, 2017 20:11 UTC Amendment | AVANOS MEDICAL, INC. HYH · Entity 28189 | Tax withholdingCommon Stock | 1,015 | $28.16 | $28,582.40 |
DisclosureSEC source: 0001606036-17-000011 · primary_doc.xml · nonDerivative · entry 1 Lowery Christopher M · CIK 0001623959 · SVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,563 F1 · shares: Due to a calculation error, the original Form 4 filed on May 3, 2016 incorrectly reported the number of securities withheld. The value reflects the actual amount of securities withheld in the transaction. F2 · balance_after: The original Form 4 filed on May 3, 2016 is amended by this Form 4 amendment to reflect the correct number of shares beneficially owned by the Reporting Person after the transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.